Avastin to be voted by FDA for breast cancer treatment_Health--China Economic Net

Avastin to be voted by FDA for breast cancer treatment_Health--China Economic Net: "An FDA panel will meet Wednesday to vote whether Avastin, the cancer drug of Genentech, can win an additional approval as a treatment for breast cancer. Data from an Avastin study released by the FDA on Monday showed that Avastin achieved its main goal of extending the period before cancer worsens but failed to extent the overall survival. Moreover, it was already known that Avastin can cause serious side effects and even some deaths. "